Boston Scientific is purchasing heart-device company Penumbra for roughly $14.5 billion in cash and stock, marking the largest deal in two decades for the medtech company with a large Minnesota ...

Boston Scientific will buy Penumbra for $14.5 billion, or $374 a share, expanding its cardiovascular reach. Penumbra stock ...

Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...

With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

Boston Scientific’s $374/share Penumbra deal boosts mechanical thrombectomy exposure and growth. Click here to learn more ...

The proportion of patients with postoperative pulmonary complications in the first 5 days after thoracic surgery did not ...

Dr. Sina Bari, a practicing surgeon and AI healthcare leader at data company iMerit, has seen firsthand how ChatGPT can lead ...

A 1000 ng/mL D-dimer threshold safely rules out pulmonary embolism in low-likelihood patients, reducing unnecessary chest imaging in emergency care.

Medical science can typically provide a clear explanation of the intricacies of the human body. However, there are times when ...

Strategic investment follows a transformative year marked by the national launch of the AVENTUS thrombectomy system.

Doug Koke died on Dec. 31 at age 73. He was a local businessowner and shaped the Oregon Harley-Davidson ride-in tradition for ...

Supported by the Israel Innovation Authority, the study aims to speed right-ventricular assessment in suspected ...